ABSTRACT

Non- systemic or systemic fungal infections affects the individuals who make him seriously ill with confirmed risk factors such as those frequently found in transplant recipients. Unfortunately, they are mostly diagnosed late, when the efficacy of the available treatments is low, often less than 50%, and the cost in terms of lives lost, hospital length of stay, and total hospital costs is substantially increased. The choice of a prophylactic agent should be based upon its ease of administration, lack of adverse effects, reduced likelihood of potential drug interactions, and its efficacy in patients with established risk factors and comorbid disease processes that include renal, hepatic, and chronic pulmonary disease. The indications for the use of currently available antifungal agents, their adverse effects, drug interactions, ease of dosing, and applicability in patients with preexisting disease states, and especially in liver transplant recipients, are presented in this review paper. Keywords- Non- systemic, systemic fungal infections, treatments
Publication date: 01/07/2023

https://ijbpas.com/pdf/2023/July/MS_IJBPAS_2023_7020.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2023/12.7.7020